CXCR2 and neoplasm: It is thus possible that tumor cells up-regulate IL-8 to compensate for the reduced VEGF activity, which in turn exploits both the angiogenic CXCR2 pathway, as well as indirectly transactivating the angiogenic VEGFR2 pathway.